(Q35824531)

10 August 2017

1 reference

title

Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients (English)

1 reference

systemic lupus erythematosus

10 August 2017

1 reference

1 reference

0 references

author name string

P I Sidiropoulos

series ordinal

1

1 reference

PubMed ID

15230298

10 August 2017

D T Boumpas

series ordinal

2

1 reference

10 August 2017

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

13

1 reference

10 August 2017

5

1 reference

10 August 2017

391-397

1 reference

The role of CD40 in the regulation of humoral and cell-mediated immunity

10 August 2017

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

CD40 and its ligand in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

CD40-CD40 ligand interaction in autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

The prognosis of lupus nephritis in African-Americans: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

The soluble CD40 ligand sCD154 in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Distinct T Cell/Renal Tubular Epithelial Cell Interactions Define Differential Chemokine Production: Implications for Tubulointerstitial Injury in Chronic Glomerulonephritides

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

What's in the pipeline? New immunosuppressive drugs in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Survival of long-lived plasma cells is independent of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Expression of functional CD40 by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Activation of human dendritic cells through CD40 cross-linking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

Soluble CD40 Ligand in Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203304LU1032OA

10.1191/0961203304LU1032OA

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15230298